Impact of the COVID-19 Pandemic on Lung Cancer Screening Program and Subsequent Lung Cancer

BACKGROUND: Low-dose CT (LDCT) screening reduces lung cancer mortality by at least 20%. The COVID-19 pandemic required an unprecedented shutdown in our institutional LDCT program. The purpose of this study was to examine the impact of COVID-19 on lung cancer screening and subsequent cancer diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Haren, Robert M., Delman, Aaron M., Turner, Kevin M., Waits, Brandy, Hemingway, Mona, Shah, Shimul A., Starnes, Sandra L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Southern Surgical Association Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947221/
https://www.ncbi.nlm.nih.gov/pubmed/33346080
http://dx.doi.org/10.1016/j.jamcollsurg.2020.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947221/
https://www.ncbi.nlm.nih.gov/pubmed/33346080
http://dx.doi.org/10.1016/j.jamcollsurg.2020.12.002

Ejemplares similares